Please use this identifier to cite or link to this item: doi:10.22028/D291-36709
Title: Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease : results from COSYCONET
Author(s): Trudzinski, Franziska C.
Jörres, Rudolf A.
Alter, Peter
Walter, Julia
Watz, Henrik
Koch, Andrea
John, Matthias
Lommatzsch, Marek
Vogelmeier, Claus F.
Kauczor, Hans-Ulrich
Welte, Tobias
Behr, Jürgen
Tufman, Amanda
Bals, Robert
Herth, Felix J. F.
Kahnert, Kathrin
Language: English
Title: Scientific Reports
Volume: 12
Issue: 1
Publisher/Platform: Springer Nature
Year of Publication: 2022
Free key words: Medical research
Prognosis
Respiratory tract diseases
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: In patients with COPD, it has not been comprehensively assessed whether the predictive value of comorbidities for mortality difers between men and women. We therefore aimed to examine sex diferences of COPD comorbidities in regard with prognosis by classifying comorbidities into a comorbidome related to extrapulmonary disorders and a pulmorbidome, referring to pulmonary disorders. The study population comprised 1044 women and 1531 men with the diagnosis of COPD from COSYCONET, among them 2175 of GOLD grades 1–4 and 400 at risk. Associations of comorbidities with mortality were studied using Cox regression analysis for men and women separately. During the follow-up (median 3.7 years) 59 women and 159 men died. In men, obesity, hypertension, coronary artery disease, liver cirrhosis, osteoporosis, kidney disease, anaemia and increased heart rate (HR) predict mortality, in women heart failure, hyperuricemia, mental disorders, kidney disease and increased HR (p< 0.05 each). Regarding the pulmorbidome, signifcant predictors in men were impairment in difusion capacity and hyperinfation, in women asthma and hyperinfation. Similar results were obtained when repeating the analyses in GOLD 1–4 patients only. Gender diferences should be considered in COPD risk assessment for a tailored approach towards the treatment of COPD.
DOI of the first publication: 10.1038/s41598-022-12828-8
URL of the first publication: https://www.nature.com/articles/s41598-022-12828-8
Link to this record: urn:nbn:de:bsz:291--ds-367098
hdl:20.500.11880/33353
http://dx.doi.org/10.22028/D291-36709
ISSN: 2045-2322
Date of registration: 8-Jul-2022
Description of the related object: Supplementary Information
Related object: https://static-content.springer.com/esm/art%3A10.1038%2Fs41598-022-12828-8/MediaObjects/41598_2022_12828_MOESM1_ESM.docx
Faculty: M - Medizinische Fakultät
Department: M - Innere Medizin
Professorship: M - Prof. Dr. Robert Bals
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
s41598-022-12828-8.pdf1,34 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons